Tsukasa Seya
8PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 15, 2025
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.Tomomi Kawakita, Toshiki Sekiya, Yayoi Kameda
|Jun 10, 2023
Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination.Tsukasa Seya, Masashi Shingai, Tomomi Kawakita
|Dec 23, 2022
Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement.Tsukasa Seya, Megumi Tatematsu, Misako Matsumoto
|Apr 28, 2022
Prophylactic Vaccine Targeting TLR3 on Dendritic Cells Ameliorates Eosinophilic Pneumonia in a Mouse SARS-CoV Infection Model.Naoko Iwata-Yoshikawa, Noriyo Nagata, Hiromi Takaki
|May 24, 2018
Vaccine immunotherapy with ARNAX induces tumor-specific memory T cells and durable anti-tumor immunity in mouse models.Yohei Takeda, Sumito Yoshida, Ken Takashima
Pageof 2
Frequent Collaborators
4 joint publications
Misako Matsumoto
2 joint publications
Masashi Shingai
2 joint publications
Tomomi Kawakita
1 joint publications
Hiroaki Shime
1 joint publications
Marumi Ohno
1 joint publications
Yuki Anraku
1 joint publications
Yasushi Itoh
1 joint publications
Akihiko Sato
1 joint publications
Yasuhiko Suzuki
1 joint publications
Lorena E Brown
